Oyster Point Pharma Inc.

NASDAQ: OYST · Real-Time Price · USD
11.17
0.00 (0.00%)
At close: Dec 30, 2022, 10:00 PM

Oyster Point Pharma Revenue Breakdown

Period Ending Dec 31, 2021
License Revenue 18.39M
License Revenue Growth n/a
Milestone Revenue Revenue 5M
Milestone Revenue Revenue Growth n/a
Product Revenue 1.15M
Product Revenue Growth n/a

Operating Expense Breakdown

Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Selling, General, and Administrative Revenue 34.24M 42.11M 39.9M 38.55M 28.5M 15.3M 13.09M 10.54M 8.11M 6.94M 5.59M 5.13M 3.81M 3.13M 1.6M 704K 916K
Selling, General, and Administrative Revenue Growth -18.68% +5.54% +3.50% +35.28% +86.30% +16.83% +24.25% +29.89% +16.89% +24.17% +9.01% +34.60% +21.62% +95.14% +127.98% -23.14% n/a
Research and Development Revenue 3.91M 4.66M 4.68M 5.46M 6.21M 6.73M 5.83M 11.71M 8.21M 8.55M 11.34M 15.03M 8.09M 8.1M 2.4M 3.35M 5.78M
Research and Development Revenue Growth -16.10% -0.36% -14.30% -12.10% -7.67% +15.48% -50.22% +42.59% -4.02% -24.57% -24.57% +85.88% -0.16% +236.84% -28.10% -42.08% n/a
Sales and Marketing Revenue 22.09M 28.1M 26.97M 25.68M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth -21.38% +4.22% +5.03% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a